Exhibit 1.1
15,000,000 UNITS
ORACLE HEALTHCARE ACQUISITION
CORP.
UNDERWRITING AGREEMENT
February__, 2006
CRT Capital Group LLC
as Representative of the Several Underwriters
262 Harbor Drive
Stamford, CT 06902
Ladies and Gentlemen:
The undersigned, Oracle Healthcare
Acquisition Corp., a Delaware corporation (the
“Company”), hereby confirms in this Underwriting
Agreement (this “Agreement”) its agreement with CRT
Capital Group LLC (being referred to herein variously as
“you,” “CRT” or the
“Representative”) and with the other underwriters named
on Schedule I hereto for which CRT is acting as Representative (the
Representative and the other Underwriters being collectively called
the “Underwriters” or, individually, an
“Underwriter”) as follows:
1.
Purchase and Sale of Securities.
1.1
Firm Securities .
1.1.1
Purchase of Firm Units . On the basis of the
representations and warranties herein contained, but subject to the
terms and conditions herein set forth, the Company agrees to issue
and sell to the Underwriters, and the Underwriters, upon the basis
of the representations and warranties herein contained, but subject
to the conditions hereinafter stated, agree to purchase from the
Company an aggregate of 15,000,000 units (the “Firm
Units”) of the Company, at a purchase price (net of discounts
and commissions and subject to Section 3.22 hereof) of $7.60 per
Firm Unit. The Firm Units are to be offered initially to the
public (“Offering”) at the offering price of $8.00 per
Firm Unit. Each Firm Unit consists of one share of the
Company’s common stock, par value $.0001 per share
(“Common Stock”), and one warrant
(“Warrant(s)”). The shares of Common Stock and
the Warrants included in the Firm Units will be separately
transferable as promptly as practicable following the consummation
of the Offering, but in no event later than 65 days following the
consummation of the Offering; provided , however ,
that in no event will the Underwriters permit separate trading
before an audited balance sheet has been prepared reflecting
receipt by the Company of the proceeds of the Offering and the
Company has filed with the Securities and Exchange Commission (the
“Commission”) a Current Report on Form 8-K which
includes such audited balance sheet. Each Warrant entitles
its holder to exercise it to purchase one share of Common Stock for
$6.00 during the period commencing on the later of the consummation
by the Company of its “Business Combination” or one
year from the effective date (“Effective Date”) of the
Registration Statement (as defined in Section 2.1.1 hereof) and
terminating on the four-year anniversary of the Effective Date, or
earlier upon redemption. “Business Combination”
shall mean the acquisition by the Company, whether by merger,
capital stock exchange, asset or stock acquisition or other similar
type of transaction or a combination of the foregoing, of an
operating company in the healthcare industry (as described more
fully in the Registration Statement). The Firm Units, the
Shares of Common Stock and the Warrants included in the Firm Units
and the shares of Common Stock issuable upon exercise of the
Warrants are hereinafter referred to collectively as the
“Securities”.
1.1.2
Payment and Delivery . Delivery and payment for the
Firm Units shall be made at 1:00 P.M., New York time, on the
third business day following the date of this Agreement (or the
fourth business day following the date of this Agreement, if this
Agreement is executed after 4:30 p.m., New York time) or at such
earlier time as shall be agreed upon by the Representative and the
Company at the offices of the Representative or at such other place
as shall be agreed upon by the Representative and the
Company. The hour and date of delivery and payment for the
Firm Units is called the “Closing Date.” Payment
for the Firm Units shall be made on the Closing
Date at the Representative’s
election by wire transfer in Federal (same day) funds or by
certified or bank cashier’s check(s) in New York Clearing
House funds, payable as follows: $113,500,000 of the proceeds
received by the Company for the Firm Units shall be deposited in
the trust account established by the Company as described in the
Registration Statement (“Trust Account”) pursuant to
the terms of the Trust Agreement (as defined below in Section 2.22
hereof) and the remaining proceeds shall be paid to the order of
the Company upon delivery to the Representative of certificates (in
form and substance reasonably satisfactory to the Representative)
representing the Firm Units (or through the facilities of the
Depository Trust Company (“DTC”)) for the account of
the Representative. The Firm Units shall be registered in
such name or names and in such authorized denominations as the
Representative may request in writing at least two full business
days prior to the Closing Date. The Company will permit the
Representative to examine and package the Firm Units for delivery,
at least one full business day prior to the Closing Date. The
Company shall not be obligated to sell or deliver the Firm Units
except upon tender of payment by the Representative for all the
Firm Units.
2.
Representations and Warranties of the Company . The
Company represents and warrants to the Underwriters as
follows:
2.1
Filing of the Registration Statement .
2.1.1
Pursuant to the Securities Act . The Company has filed
with the Commission on Form S-1 (File No. 333-128748) a
registration statement, including a prospectus, relating to the
Offering, which registration statement has been prepared in
conformity with the requirements of the Securities Act, and the
rules and regulations (“Regulations”) of the Commission
under the Securities Act of 1933, as amended (the “Securities
Act”). The registration statement as amended at the
time it becomes effective, including the information (if any)
deemed to be part of the registration statement at the time of
effectiveness pursuant to Rule 430A under the Securities Act, is
hereinafter referred to as the “Registration
Statement”; the prospectus in the form first filed with the
Commission pursuant to and within the time limits described in Rule
424(b) is hereinafter referred to as the “Prospectus.”
If the Company has filed an abbreviated registration statement to
register additional Firm Units pursuant to Rule 462(b) under the
Securities Act (the “Rule 462 Registration Statement”),
then any reference herein to the term “Registration
Statement” shall be deemed to include such Rule 462
Registration Statement. For purposes of this Agreement,
“Time of Sale” means [ ] p.m., New York City time, on
the date of this Agreement. Prior to the Time of Sale, the
Company prepared a preliminary prospectus, dated February __, 2006,
for distribution by the Underwriters (the “Preliminary
Prospectus”). If, subsequent to the date of this
Agreement, the Company or the Representative has determined that
the Preliminary Prospectus included an untrue statement of a
material fact or omitted a statement of material fact necessary to
make the statements therein, in the light of the circumstances
under which they were made, not misleading and have agreed to
provide an opportunity to purchasers of the Firm Units to terminate
their old purchase contracts and enter into new purchase contracts,
then the Preliminary Prospectus will be deemed to include any
additional information available to purchasers at the time of entry
into the first such new purchase contract.
2.1.2
Pursuant to the Exchange Act . The Company has filed
with the Commission a Form 8-A (File Number 000-51785) providing
for the registration under the Securities Exchange Act of 1934, as
amended (“Exchange Act”), of the Firm Units, the Common
Stock and the Warrants. The registration of the Firm Units,
Common Stock and Warrants under the Exchange Act is effective as of
the date hereof.
2.2
No Stop Orders, Etc. Neither the Commission nor, to
the best of the Company’s knowledge, any state regulatory
authority has issued any order or threatened to issue any order
preventing or suspending the effectiveness of the Registration
Statement or the use of the Preliminary Prospectus or the
Prospectus, or has instituted or, to the best of the
Company’s knowledge, threatened to institute any proceedings
with respect to such an order.
2.3
Disclosures in the Registration Statement .
2.3.1
10b-5 Representation . The Registration Statement has
been declared effective by the Commission on the date hereof.
At the time the Registration Statement became effective and at the
Closing Date, the Registration Statement contains or will contain,
as applicable, and the Prospectus when first filed with the
Commission and at the Closing Date, will contain, all material
statements that are required to be stated therein in
2
accordance with the Securities Act
and the Regulations, and conforms or will conform as applicable in
all material respects to the requirements of the Securities Act and
the Regulations; neither the Registration Statement nor the
Prospectus, nor any amendment or supplement thereto, on such dates,
contains or will contain any untrue statement of a material fact or
omits or will omit to state any material fact required to be stated
therein or necessary to make the statements therein, in light of
the circumstances under which they were made, not misleading.
The Preliminary Prospectus, when first filed with the Commission,
at the Time of Sale and at the Closing Date, complied or will
comply, as applicable, in all material respects with the applicable
provisions of the Securities Act and the Regulations and did not
and will not contain an untrue statement of a material fact or omit
to state any material fact required to be stated therein or
necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading. No
statement of material fact included in the Prospectus has been
omitted from the Preliminary Prospectus or the Registration
Statement and no statement of material fact included in the
Preliminary Prospectus or the Registration Statement that is
required to be included in the Prospectus has been omitted
therefrom. Nothing has come to the attention of the Company
that has caused the Company to believe that the statistical and
market-related data included in the Preliminary Prospectus, the
Registration Statement and the Prospectus is not based on or
derived from sources that are reliable and accurate (in accordance
with the methodologies used to derive such statistical and
market-related data set forth in the underlying source material) in
all material respects.
2.3.2
Disclosure of Agreements . The agreements and
documents described in the Preliminary Prospectus, the Registration
Statement and the Prospectus conform to the descriptions thereof
contained therein and there are no agreements or other documents
required to be described in the Preliminary Prospectus, the
Registration Statement or the Prospectus or to be filed with the
Commission as exhibits to the Registration Statement, that have not
been so described or filed. Each agreement or other
instrument (however characterized or described) to which the
Company is a party or by which its property or business is or may
be bound or affected and (i) that is referred to in the Preliminary
Prospectus or the Prospectus, or (ii) is material to the
Company’s business, has been duly and validly executed by the
Company, is in full force and effect and is enforceable against the
Company and, to the Company’s knowledge, the other parties
thereto, in accordance with its terms, except (x) as such
enforceability may be limited by bankruptcy, insolvency,
reorganization or similar laws affecting creditors’ rights
generally, (y) as enforceability of any indemnification or
contribution provision may be limited under the federal and state
securities laws, and (z) that the remedy of specific performance
and injunctive and other forms of equitable relief may be subject
to the equitable defenses and to the discretion of the court before
which any proceeding therefor may be brought, and none of such
agreements or instruments has been assigned by the Company, and
neither the Company nor, to the best of the Company’s
knowledge, any other party is in breach or default thereunder and,
to the best of the Company’s knowledge, no event has occurred
that, with the lapse of time or the giving of notice, or both,
would constitute a breach or default thereunder. To the best
of the Company’s knowledge, performance by the Company of the
material provisions of such agreements or instruments will not
result in a violation of any existing applicable law, rule,
regulation, judgment, order or decree of any governmental agency or
court, domestic or foreign, having jurisdiction over the Company or
any of its assets or businesses, including, without limitation,
those relating to environmental laws and regulations.
2.3.3
Prior Securities Transactions . No securities of the
Company have been sold by the Company or by or on behalf of, or for
the benefit of, any person or persons controlling, controlled by,
or under common control with the Company since the formation of the
Company, except as disclosed in the Preliminary Prospectus, the
Registration Statement and the Prospectus.
2.3.4
Regulations . The disclosures in the Preliminary
Prospectus, the Registration Statement and the Prospectus
concerning the effects of federal, state and local regulation on
the Company’s business as described in the Preliminary
Prospectus, the Registration Statement and the Prospectus are
correct in all material respects and do not omit to state a
material fact necessary to make the statements therein, in light of
the circumstances under which they were made, not
misleading.
2.4
Changes After Dates in the Registration Statement
.
2.4.1
No Material Adverse Change . Since the respective
dates as of which information is given in the Preliminary
Prospectus, the Registration Statement and the Prospectus, except
as otherwise specifically stated therein, (i) there has been no
material adverse change in the condition, financial or otherwise,
or business
3
prospects of the Company, (ii) there
have been no material transactions entered into by the Company,
other than as contemplated pursuant to this Agreement or disclosed
in the Preliminary Prospectus, the Registration Statement and the
Prospectus, and (iii) no member of the Company’s management
has resigned from any position with the Company.
2.4.2
Recent Securities Transactions . Subsequent to the
respective dates as of which information is given in the
Registration Statement and the Prospectus, and except as may
otherwise be indicated or contemplated herein or therein, the
Company has not (i) issued any securities or incurred any liability
or obligation, direct or contingent, for borrowed money; or (ii)
declared or paid any dividend or made any other distribution on or
in respect to its equity securities.
2.5
Independent Accountants . Rothstein Kass & Company
PC (“Rothstein Kass”), whose report is filed with the
Commission as part of the Registration Statement, are independent
accountants as required by the Securities Act and the
Regulations. Rothstein Kass has not, during the periods
covered by the financial statements included in the Prospectus,
provided to the Company any non-audit services, as such term is
used in Section 10A(g) of the Exchange Act.
2.6
Financial Statements . The financial statements,
including the notes thereto included in the Preliminary Prospectus,
the Registration Statement and the Prospectus, fairly present the
financial position, the results of operations and the cash flows of
the Company at the dates and for the periods to which they apply;
and such financial statements have been prepared in conformity with
United States generally accepted accounting principles
(“GAAP”), consistently applied throughout the periods
involved. The Preliminary Prospectus, the Registration
Statement and the Prospectus disclose all material off-balance
sheet transactions, arrangements, obligations (including contingent
obligations), and other relationships of the Company with
unconsolidated entities or other persons that may have a material
current or future effect on the Company’s financial
condition, changes in financial condition, results of operations,
liquidity, capital expenditures, capital resources, or significant
components of revenues or expenses.
2.7
Authorized Capital; Options; Etc. The Company had at
the date or dates indicated in the Preliminary Prospectus, the
Registration Statement and the Prospectus duly authorized, issued
and outstanding capital stock as set forth in the Preliminary
Prospectus, the Registration Statement and the Prospectus.
Based on the assumptions stated in the Preliminary Prospectus, the
Registration Statement and the Prospectus, the Company will have on
the Closing Date the adjusted stock capitalization set forth
therein. Except as set forth in, or contemplated by, the
Preliminary Prospectus, the Registration Statement and the
Prospectus, on the Effective Date and on the Closing Date, there
will be no options, warrants, or other rights to purchase or
otherwise acquire any authorized but unissued shares of Common
Stock or any security convertible into shares of Common Stock, or
any contracts or commitments to issue or sell shares of Common
Stock or any such options, warrants, rights or convertible
securities.
2.8
Valid Issuance of Securities; Etc.
2.8.1
Outstanding Securities . All issued and outstanding
securities of the Company have been duly authorized and validly
issued and are fully paid and non-assessable; the holders thereof
have no rights of rescission with respect thereto, and are not
subject to personal liability by reason of being such holders; and
none of such securities were issued in violation of the preemptive
rights of any holders of any security of the Company or similar
contractual rights granted by the Company. The authorized
Common Stock conforms to all statements relating thereto contained
in the Preliminary Prospectus, the Registration Statement and the
Prospectus. The offers and sales of the outstanding Common
Stock were at all relevant times either registered under the
Securities Act and the applicable state securities or Blue Sky laws
or, based in part on the representations and warranties of the
purchasers of such shares of Common Stock, exempt from such
registration requirements.
2.8.2
Securities Sold Pursuant to this Agreement . The
Securities have been duly authorized and, when issued and paid for,
will be validly issued, fully paid and non-assessable; the holders
thereof are not and will not be subject to personal liability by
reason of being such holders; the Securities are not and will not
be subject to the preemptive rights of any holders of any security
of the Company or similar contractual rights granted by the
Company; and all corporate action required to be taken for the
authorization, issuance and sale of the Securities has been duly
and validly taken. The Securities conform in all material
respects to all statements with respect thereto
4
contained in the Preliminary
Prospectus, the Registration Statement and the Prospectus.
When issued, the Warrants will constitute valid and binding
obligations of the Company to issue and sell, upon exercise thereof
and payment of the exercise price therefor, the number and type of
securities of the Company called for thereby in accordance with the
terms thereof and the Warrants are enforceable against the Company
in accordance with their respective terms, except (i) as such
enforceability may be limited by bankruptcy, insolvency,
reorganization or similar laws affecting creditors’ rights
generally, (ii) as enforceability of any indemnification or
contribution provision may be limited under the federal and state
securities laws, and (iii) that the remedy of specific performance
and injunctive and other forms of equitable relief may be subject
to equitable defenses and to the discretion of the court before
which any proceeding therefor may be brought.
2.9
Registration Rights of Third Parties . Except as set
forth in the Preliminary Prospectus and the Prospectus, no holders
of any securities of the Company or any rights exercisable for or
convertible or exchangeable into securities of the Company have the
right to require the Company to register any such securities of the
Company under the Securities Act or to include any such securities
in a registration statement to be filed by the Company.
2.10
Validity and Binding Effect of Agreements . This
Agreement, the Warrant Agreement (as defined in Section 2.21
hereof), the Trust Agreement (as defined in Section 2.22 hereof),
those certain letter agreements (each substantially in the form
filed as Exhibits 10.1 through 10.1.10 to the Registration
Statement), pursuant to which each of the Initial Stockholders (as
defined in Section 2.14 hereof), Larry N. Feinberg, Mark A. Radzik,
Per G. H. Lofberg and Kevin C. Johnson agree to certain matters,
including but not limited to, certain matters described as being
agreed to by them under the “Proposed Business” section
of the Prospectus (“Insider Letters”), the Founding
Director Warrant Purchase Agreement (as defined in Section 2.29
hereof), and the Escrow Agreement (substantially in the form filed
as Exhibit 10.2 to the Registration Statement), whereby the Common
Stock owned by the Initial Stockholders prior to the date hereof
will be placed in escrow until three years after the closing of the
Offering (the “Escrow Agreement”), and the Office
Services Agreement (as defined in Section 2.28 hereof) have been
duly and validly authorized by the Company and constitute the valid
and binding agreements of the Company, enforceable against the
Company in accordance with their respective terms, except (i) as
such enforceability may be limited by bankruptcy, insolvency,
reorganization or similar laws affecting creditors’ rights
generally, (ii) as enforceability of any indemnification or
contribution provision may be limited under the federal and state
securities laws, and (iii) that the remedy of specific performance
and injunctive and other forms of equitable relief may be subject
to equitable defenses and to the discretion of the court before
which any proceeding therefor may be brought.
2.11
No Conflicts, Etc . The execution, delivery, and
performance by the Company of this Agreement, the Warrant
Agreement, the Founding Director Warrant Purchase Agreement, the
Trust Agreement, the Insider Letters, the Office Services Agreement
and the Escrow Agreement, the consummation by the Company of the
transactions herein and therein contemplated and the compliance by
the Company with the terms hereof and thereof do not and will not,
with or without the giving of notice or the lapse of time or both
(i) result in a breach of, or conflict with any of the terms and
provisions of, or constitute a default under, or result in the
creation, modification, termination or imposition of any lien,
charge or encumbrance upon any property or assets of the Company
pursuant to the terms of any agreement or instrument to which the
Company is a party except pursuant to the Trust Agreement referred
to in Section 2.22 hereof; (ii) result in any violation of the
provisions of the Amended and Restated Certificate of Incorporation
or its Amended and Restated Bylaws of the Company; or (iii) violate
any existing applicable law, rule, regulation, judgment, order or
decree of any governmental agency or court, domestic or foreign,
having jurisdiction over the Company or any of its properties or
business, except, in the case of clauses (i) and (iii), to the
extent that such breach, violation or conflict would not,
individually or in the aggregate, be reasonably expected to have a
material adverse effect on the Company.
2.12
No Defaults; Violations . No material default exists
in the due performance and observance of any term, covenant or
condition of any material license, contract, indenture, mortgage,
deed of trust, note, loan or credit agreement, or any other
agreement or instrument evidencing an obligation for borrowed
money, or any other material agreement or instrument to which the
Company is a party or by which the Company may be bound or to which
any of the properties or assets of the Company is subject.
The Company is not in violation of any term or provision of its
Amended and Restated Certificate of Incorporation or its Amended
and Restated Bylaws or in violation of any material franchise,
license, permit, applicable law, rule, regulation, judgment or
decree of any governmental agency or court, domestic or foreign,
having jurisdiction over the Company or any of its properties or
businesses.
5
2.13
Corporate Power; Licenses; Ownership .
2.13.1
Conduct of Business . The Company has all requisite
corporate power and authority, and has all necessary
authorizations, approvals, orders, licenses, certificates and
permits of and from all governmental regulatory officials and
bodies that it needs as of the date hereof to conduct its business
as described in the Preliminary Prospectus, the Registration
Statement and the Prospectus. The disclosures in the
Preliminary Prospectus, the Registration Statement and the
Prospectus concerning the effects of federal, state and local
regulation on this offering and the Company’s business
purpose as described in the Preliminary Prospectus, the Prospectus
and the Registration Statement are correct in all material respects
and do not omit to state a material fact required to be stated
therein or necessary in order to make the statements therein, in
light of the circumstances under which they were made, not
misleading.
2.13.2
Transactions Contemplated Herein . The Company has all
corporate power and authority to enter into this Agreement and to
carry out the provisions and conditions hereof, and all consents,
authorizations, approvals and orders required in connection
therewith have been obtained. No consent, authorization or
order of, and no filing with, any court, government agency or other
body is required for the valid issuance, sale and delivery, of the
Securities and the consummation of the transactions and agreements
contemplated by this Agreement, the Warrant Agreement, the Trust
Agreement, the Insider Letters, the Warrant Purchase Agreement, the
Office Services Agreement and the Escrow Agreement and as
contemplated by the Prospectus, except with respect to applicable
federal and state securities laws.
2.13.3
Ownership . Except as set forth in the Preliminary
Prospectus, the Registration Statement and the Prospectus, the
Company owns or has valid leasehold interests in all material
properties and assets required for the operation of its business as
now conducted or as presently proposed to be conducted, including
those described in the Preliminary Prospectus, the Registration
Statement and the Prospectus as being owned by it; and the Company
has good and marketable title to all properties and assets owned by
it material to its business in each case free from liens,
encumbrances and defects that would materially affect the value
thereof or materially interfere with the use made or to be made
thereof by the Company. All real property leases to which the
Company is a party are valid, subsisting and, to the knowledge of
the Company, enforceable by the Company, in each case with no
exceptions that would materially interfere with the use made or to
be made thereof by the Company and the Company enjoys peaceful and
undisturbed possession under all such leases to which it is a party
as lessee. The Company owns or possesses, or can acquire on a
timely basis and on commercially reasonable terms, all material
trademarks, trade names and other rights to inventions, know-how,
patents, copyrights, confidential information and other
intellectual property necessary for the Company’s business as
currently proposed to be conducted.
2.14
D&O Questionnaires . To the best of the
Company’s knowledge, all information contained in the
director and officer questionnaires and NASD supplemental
questionnaires (“Questionnaires”) completed by Larry N.
Feinberg, Mark A. Radzik, Per. G. H. Lofberg, Kevin C. Johnson and
each of the Company’s stockholders of record immediately
prior to the Offering (“Initial Stockholders”) and
provided to the Representative as an exhibit to his or her Insider
Letter (as defined in Section 2.10 hereof) is true and correct and
the Company has not become aware of any information which would
cause the information disclosed in the questionnaires completed by
each Initial Stockholder, Per. G. H. Lofberg or Kevin C. Johnson to
become inaccurate and incorrect.
2.15
Litigation; Governmental Proceedings . There is no
action, suit, proceeding, inquiry, arbitration, investigation,
litigation or governmental proceeding pending or, to the best of
the Company’s knowledge, threatened against, or involving the
Company, which has not been disclosed in the Preliminary
Prospectus, the Prospectus or the Registration
Statement.
2.16
Good Standing . The Company has been duly organized
and is validly existing as a corporation and is in good standing
under the laws of its state of incorporation, and is duly qualified
to do business and is in good standing as a foreign corporation in
each jurisdiction in which its ownership or lease of property or
the conduct of business requires such qualification, except where
the failure to qualify would not have a material adverse effect on
the Company.
2.17
[Reserved.]
6
2.18
Transactions Affecting Disclosure to NASD .
2.18.1
Finder’s Fees . Except as described in the
Preliminary Prospectus, the Registration Statement and the
Prospectus, there are no claims, payments, arrangements, agreements
or understandings relating to the payment of a finder’s,
consulting or origination fee by the Company or any Initial
Stockholder with respect to the sale of the Securities hereunder or
any other arrangements, agreements or understandings of the Company
or, to the best of the Company’s knowledge, any Initial
Stockholder or director that may affect the Underwriters’
compensation, as determined by the National Association of
Securities Dealers, Inc. (“NASD”).
2.18.2
Payments Within Twelve Months . The Company has not
made any direct or indirect payments (in cash, securities or
otherwise) (i) to any person, as a finder’s fee, consulting
fee or otherwise, in consideration of such person raising capital
for the Company or introducing to the Company persons who raised or
provided capital to the Company, (ii) to any NASD member or (iii)
to any person or entity that has any direct or indirect affiliation
or association with any NASD member, within the twelve months prior
to the Effective Date.
2.18.3
Use of Proceeds . None of the net proceeds of the
Offering will be paid by the Company to any participating NASD
member or its affiliates, except as specifically authorized herein
and except as may be paid in connection with a Business Combination
as contemplated by the Prospectus.
2.18.4
Insiders’ NASD Affiliation . Based on the
Questionnaires distributed to such persons, except as set forth on
Schedule 2.18.4, no officer, director or any beneficial owner of
the Company’s unregistered securities has any direct or
indirect affiliation or association with any NASD member. The
Company will advise the Representative and its counsel if it learns
that any officer or director or owner of at least 5% of the
Company’s outstanding Common Shares is or becomes an
affiliate or associated person of an NASD member participating in
the Offering.
2.19
Foreign Corrupt Practices Act . Neither the Company
nor any of the Initial Stockholders or any other person acting on
behalf of the Company has, directly or indirectly, given or agreed
to give any money, gift or similar benefit (other than legal price
concessions to customers in the ordinary course of business) to any
customer, supplier, employee or agent of a customer or supplier, or
official or employee of any governmental agency or instrumentality
of any government (domestic or foreign) or any political party or
candidate for office (domestic or foreign) or any political party
or candidate for office (domestic or foreign) or other person who
was, is, or may be in a position to help or hinder the business of
the Company (or assist it in connection with any actual or proposed
transaction) that (i) might subject the Company to any damage or
penalty in any civil, criminal or governmental litigation or
proceeding, (ii) if not given in the past, might have had a
material adverse effect on the assets, business or operations of
the Company as reflected in any of the financial statements
contained in the Preliminary Prospectus, the Registration Statement
and the Prospectus or (iii) if not continued in the future, might
adversely affect the assets, business, operations or prospects of
the Company.
2.20
Officer’s Certificate . Any certificate signed
by any duly authorized officer of the Company and delivered to the
Representative or to the Representative’s counsel shall be
deemed a representation and warranty by the Company to the
Underwriters as to the matters covered thereby.
2.21
Warrant Agreement . The Company has entered into a
warrant agreement with respect to the Warrants with Continental
Stock Transfer & Trust Company substantially in the form filed
as Exhibit 4.4 to the Registration Statement (the “Warrant
Agreement”).
2.22
Investment Management Trust Agreement . The Company
has entered into the Investment Management Trust Agreement with
respect to certain proceeds of the Offering substantially in the
form filed as Exhibit 10.5 to the Registration Statement (the
“Trust Agreement”).
2.23
Covenants Not to Compete . Except as set forth on
Schedule 2.23, no Initial Stockholder, employee, officer or
director of the Company is subject to any noncompetition agreement
or non-solicitation agreement with any employer or prior employer
which could materially affect his ability to be an Initial
Stockholder, employee, officer and/or director of the
Company.
7
2.24
Investment Company Act . The Company is not and, after
giving effect to the offering and sale of the Firm Units
contemplated hereunder and the application of the net proceeds from
such sale as described in the Registration Statement and the
Prospectus, will not be an “investment company” within
the meaning of such term under the Investment Company Act of 1940,
as amended, and the rules and regulations of the Commission
thereunder.
2.25
Rule 419 Under the Exchange Act . Upon delivery and
payment for the Firm Units on the Closing Date, the Company will
not be subject to Rule 419 under the Securities Act and none of the
Company’s outstanding securities will be deemed to be a
“penny stock” as defined in rule 3a-51-1 under the
Exchange Act.
2.26
Subsidiaries . The Company does not own an interest in
any corporation, partnership, limited liability company, joint
venture, trust or other business entity.
2.27
Related Party Transactions . There are no business
relationships or related party transactions involving the Company
or any other person required to be described in the Preliminary
Prospectus or the Prospectus that have not been described as
required.
2.28
Administrative Services . The Company has entered into
an agreement (the “Office Services Agreement”) with
Oracle Investment Management, Inc. (“OIM”)
substantially in the form annexed as Exhibit 10.8 to the
Registration Statement pursuant to which OIM will make available to
the Company office space and general and secretarial support for
the Company’s use for $7,500 per month.
2.29
Warrant Purchase Agreement . The Company has entered
into a Warrant Purchase Agreement, substantially in the form filed
as Exhibit 10.7 to the Registration Statement, pursuant to which
each of Larry N. Feinberg and Joel D. Liffmann
(collectively, the “Founding Directors”) or their
designees and/or affiliates agrees to purchase a certain number of
the Company’s warrants (the “Founding Director
Warrants”) in a registered offering concurrent with the
Offering (the “Founding Director Warrant Purchase
Agreement”).
2.30
Sarbanes-Oxley Act . The Company has taken all
necessary actions to ensure that it is in compliance with all
provisions of the Sarbanes-Oxley Act with which the Company is
required to comply.
3.
Covenants of the Company . The Company covenants and
agrees as follows:
3.1
Amendments to the Registration Statement . The Company
will deliver to the Representative, prior to filing, any amendment
or supplement to the Registration Statement or the Prospectus
proposed to be filed after the Effective Date and not file any such
amendment or supplement to which the Representative shall
reasonably object in writing.
3.2
Federal Securities Laws .
3.2.1
Compliance . During the time when a Prospectus (or in
lieu thereof the notice referred to under Rule 173(a) under the
Act) is required to be delivered under the Securities Act, the
Company will use all reasonable efforts to comply with all
requirements imposed upon it by the Securities Act, the Regulations
and the Exchange Act and by the regulations under the Exchange Act,
as from time to time in force, so far as necessary to permit the
continuance of sales of or dealings in the Securities in accordance
with the provisions hereof and the Prospectus. If at any time
when a Prospectus (or in lieu thereof the notice referred to under
Rule 173(a) under the Act) relating to the Securities is required
to be delivered under the Securities Act, any event shall have
occurred as a result of which, in the opinion of counsel for the
Company or counsel for the Representative, the Prospectus, as then
amended or supplemented, includes an untrue statement of a material
fact or omits to state any material fact required to be stated
therein or necessary to make the statements therein, in light of
the circumstances under which they were made, not misleading, or if
it is necessary at any time to amend the Prospectus to comply with
the Securities Act, the Company will notify the Representative
promptly and prepare and file with the Commission, subject to
Section 3.1 hereof, an appropriate amendment or supplement in
accordance with Section 10 of the Securities Act.
8
3.2.2
Filing of Final Prospectus . The Company will file the
Prospectus (in form and substance satisfactory to the
Representative) with the Commission pursuant to the requirements of
Rule 424 of the Regulations.
3.2.3
Exchange Act Registration . Until the earlier of five
years from the Effective Date or the date that the Company is
liquidated, the Company (i) will use its best efforts to maintain
the registration of the Firm Units, Common Stock and Warrants under
the provisions of the Exchange Act and (ii) will not deregister the
Firm Units under the Exchange Act without the prior written consent
of the Representative, which consent shall not be unreasonably
withheld; provided , however , that the Company may
terminate its Exchange Act registration without the prior written
consent of the Representative in the event that all of the
outstanding voting stock of the Company is acquired by a third
party.
3.3
Blue Sky Filings . The Company will endeavor in good
faith, in cooperation with the Underwriters, to qualify the
Securities for offering and sale under the securities laws of such
jurisdictions as the Representative may reasonably designate,
provided that no such qualification shall be required in any
jurisdiction where, as a result thereof, the Company would be
subject to service of general process or to taxation as a foreign
corporation doing business in such jurisdiction. Until the
earliest of (i) five years after the effective date, (ii) the date
on which the Securities are listed or quoted, as the case may be,
on the New York Stock Exchange, the American Stock Exchange or the
Nasdaq National Market (or any successor to such entities) and
(iii) the date of the liquidation of the Company (the period from
the Effective Date to such earliest date, the “Blue Sky
Compliance Period”), in each jurisdiction where such
qualification shall be effected, the Company will, unless the
Representative agrees that such action is not at the time necessary
or advisable, use all reasonable efforts to file and make such
statements or reports at such times as are or may be required by
the laws of such jurisdiction.
3.4
Delivery to the Representative of Prospectuses . The
Company will deliver to the Representative, without charge, from
time to time during the period when the Prospectus (or in lieu
thereof the notice referred to under Rule 173(a) under the Act) is
required to be delivered under the Securities Act or the Exchange
Act, such number of copies of each Preliminary Prospectus and the
Prospectus as the Representative may reasonably request and, as
soon as the Registration Statement or any amendment or supplement
thereto becomes effective, deliver to the Representative one
original executed Registration Statements, including exhibits, and
all post-effective amendments thereto and copies of all exhibits
filed therewith or incorporated therein by reference and original
executed consents of all certified experts.
3.5
Effectiveness and Events Requiring Notice to the
Representative .
3.5.1
The Company will use its best efforts to cause the Registration
Statement to remain effective until distribution of the Securities
is complete and will notify the Representative immediately and
confirm the notice in writing (i) of the effectiveness of the
Registration Statement and any amendment thereto, (ii) of the
issuance by the Commission of any stop order or of the initiation,
or the threatening, of any proceeding for that purpose, (iii) of
the issuance by any state securities commission of any proceedings
for the suspension of the qualification of the Securities for
offering or sale in any jurisdiction or of the initiation, or the
threatening, of any proceeding for that purpose, (iv) of the
mailing and delivery to the Commission for filing of any amendment
or supplement to the Registration Statement or the Prospectus, (v)
of the receipt of any comments or request for any additional
information from the Commission, and (vi) of the happening of any
event during the period described in Section 3.4 hereof that, in
the judgment of the Company, makes any statement of a material fact
made in the Registration Statement or the Prospectus untrue or that
requires the making of any changes in the Registration Statement or
the Prospectus in order to make the statements th